CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biotest AG Company Snapshot
Biotest AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other companies in this sector in GERMANY : Evotec SE (2020 sales of 500.92 million Euro [US$610.14 million] of which 75% was EVT Execute), Eckert & Ziegler Strahlen- und Medizinte (176.14 million Euro [US$214.54 million] of which 51% was Isotope Products), and Dermapharm Holding SE (793.83 million Euro [US$966.91 million] of which 59% was Pharmaceuticals and other products).

Sales Analysis. During the first quarter of 2021, sales at Biotest AG totalled 120.00 million Euro. This is an increase of 22.8% from the 97.70 million Euro in sales at the company during the first quarter of 2020. During the previous 8 quarters, sales at Biotest AG have increased compared with the same quarter in the previous year. During the year ended December of 2020, sales at Biotest AG were 484.20 million Euro (US$589.77 million). This is an increase of 15.5% versus 2019, when the company's sales were 419.10 million Euro. This was the third consecutive year of growth at Biotest AG. Sales of Plasma and Services saw an increase of 18.2% in 2020, from 39.50 million Euro to 46.70 million Euro. Not all segments of Biotest AG experienced an increase in sales in 2020: sales of Other fell 9.1% to 7.00 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biotest AG
  Stock Performance Chart for Biotest AG
 
  Stock Data: Recent Stock Performance:
  Current Price (6/4/2021): 33.00
(Figures in Euros )
1 Week 13.8%   13 Weeks 12.2%  
4 Weeks 11.9%   52 Weeks 60.2%  
 
Biotest AG Key Data:
  Ticker: BIO3 Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 484,200,000
(Year Ending Jan 2021).
Employees: 1,928
  Currency: Euros Market Cap: 1,305,857,916
  Fiscal Yr Ends: December Shares Outstanding: 39,571,452
  Share Type: INHABIESTAMMAKTIEN Closely Held Shares: 17,783,776
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.